Koichi Takahashi

89PUBLICATIONS
307CO-AUTHORS
Predictive and prognostic markersGene and molecular therapyCardiology (incl. cardiovascular diseases)Regenerative medicine (incl. stem cells)Medical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (89)

|Aug 10, 2026
Targeting oncogenic FLT3 uncovers a ferroptosis vulnerability through selenocysteine recoding in acute myeloid leukaemia.

|Jun 11, 2026
All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE).

|May 06, 2026
Prognostic impact of ASXL1 mutations in acute myeloid leukemia treated with lower intensity therapy.

|Mar 19, 2026
Clonal dynamics of CH in CLL.

Sarah Hanache, Koichi Takahashi

|Mar 12, 2026
Immunophenotypic changes following menin inhibition in acute myeloid leukemia.

Sanam Loghavi, Aziz Farhat, Trevor J Jamison

|Feb 24, 2026
Overcoming menin inhibitor resistance in AML cells with combinations including BET proteins and a dual BRG1/BRM inhibitor.

Warren Fiskus, Christopher P Mill, Ghayas C Issa

Pageof 15

Frequent Collaborators

38 joint publications

Guillermo Garcia-Manero

36 joint publications

Courtney DiNardo

34 joint publications

Naval G Daver

32 joint publications

Tapan M Kadia